Friday, November 19, 2010
New Drug Holds Promise in Triple Negative Breast Cancer Fight
Lab studies and early trials show the drug BSI-201, or iniparib, is markedly effective in reducing tumors when used alongside other chemotherapy drugs.
An RSS feed for the weekly update of relevant headlines from TheBreastCareSite.com